Colgate-Palmolive Company (ETR:CPA)
| Market Cap | 55.88B |
| Revenue (ttm) | 17.13B |
| Net Income (ttm) | 2.48B |
| Shares Out | n/a |
| EPS (ttm) | 3.04 |
| PE Ratio | 22.55 |
| Forward PE | 21.36 |
| Dividend | 1.83 (2.65%) |
| Ex-Dividend Date | Oct 17, 2025 |
| Volume | 517 |
| Average Volume | 961 |
| Open | 69.49 |
| Previous Close | 69.61 |
| Day's Range | 69.04 - 69.49 |
| 52-Week Range | 64.53 - 92.68 |
| Beta | 0.30 |
| RSI | 57.49 |
| Earnings Date | Jan 30, 2026 |
About Colgate-Palmolive Company
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells i... [Read more]
Financial Performance
In 2024, Colgate-Palmolive Company's revenue was $20.10 billion, an increase of 3.31% compared to the previous year's $19.46 billion. Earnings were $2.89 billion, an increase of 25.61%.
Financial numbers in USD Financial StatementsNews
Colgate-Palmolive: Wide Moat And A Mispriced Future
Colgate-Palmolive (CL)'s diverse category system creates a deeper moat than its simple products suggest. It shows how shared chemistry, manufacturing flexibility and retail presence strengthen its com...
5 Top Dividend Stocks to Buy in November
For investors, it's generally wise to buy and hold companies that continually raise their dividends. There are deals in energy, healthcare, consumer staples, and even the tech space.
Colgate-Palmolive: This Dividend King Is Rebounding (Technical Analysis)
Is Colgate's Innovation Engine Enough to Revive Its Volumes?
CL bets on faster, science-led innovation and a global Colgate Total relaunch to overcome soft volumes and regain momentum.
Defensive Stocks Could Use Help Today
Many popular funds that hold stocks of companies that dabble in relatively low risk areas, such as selling toothpaste or making beverages, were falling Wednesday afternoon. The Consumer Staples Select...
Price Over Earnings Overview: Colgate-Palmolive
In the current session, Colgate-Palmolive Inc. (NYSE: CL) is trading at $79.25, after a 0.10% drop. Over the past month, the stock fell by 1.41% , and in the past year, by 16.46% . With performance l...
Don't Give Up on Dividend Stocks. 5 Dividend Kings Down Between 5% and 33% to Buy in November
The decline in consumer staples stocks shows the disconnect between the consumer economy and stock market performance. Dividend Kings are excellent choices for investors who prioritize dividend reliab...
Colgate-Palmolive Webcasts Fireside Chat at the Morgan Stanley Global Consumer & Retail Conference
NEW YORK--(BUSINESS WIRE)--Colgate-Palmolive (NYSE:CL) Chief Growth Officer, John Hazlin and Chief Financial Officer, Stan Sutula, will participate in a fireside chat at the Morgan Stanley Global Cons...
Recent Filing Shows That Rep. Julie Johnson Sold Over $12K Worth of Alaska Air Gr Stock
November 14, 2025 records indicate that Representative Julie Johnson filed a sale of Alaska Air Gr (NYSE: ALK), valued between $12,012 and $180,000. According to the November filing, the transaction ...
January 2026 Options Now Available For Colgate-Palmolive (CL)
Investors in Colgate-Palmolive Co. (Symbol: CL) saw new options begin trading today, for the January 2026 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the CL opt...
Down 15% Year to Date, Is This Dividend King a Buy?
Colgate has been a solid defensive stock, rising 352% since 2000 while boosting its dividend. Despite this, it has narrowly trailed the S&P 500's return over that time frame.
CL Quantitative Stock Analysis - Warren Buffett
Below is Validea's guru fundamental report for COLGATE-PALMOLIVE CO (CL). Of the 22 guru strategies we follow, CL rates highest using our Patient Investor model based on the published strategy of Warr...
Colgate-Palmolive (CL) Announces â¬600 Million Senior Notes Offering
Colgate-Palmolive (CL) Announces â¬600 Million Senior Notes Offering
3 Dividend Stocks Down 11%, 29%, and 41% to Buy in November
AbbVie continues to enjoy strong growth from its new blockbuster drugs, Rinvoq and Skyrizi. Colgate-Palmolive is a rock-solid dividend growth stock simply out of fashion amid the tech craze.
Colgate-Palmolive Company 2025 Q3 - Results - Earnings Call Presentation
Barclays Adjusts Colgate-Palmolive (CL) Price Target Amid Market Trends | CL Stock News
Barclays Adjusts Colgate-Palmolive (CL) Price Target Amid Market Trends | CL Stock News
Some Americans Aren't Looking to Save on Household Goods—They're 'Trading Up'
Consumers are buying more high-end toothpaste, hair care products and other staples, and less of the bargain alternatives, Procter & Gamble and Colgate-Palmolive said.
CL: UBS Lowers Price Target for Colgate-Palmolive to $90 | CL Stock News
CL: UBS Lowers Price Target for Colgate-Palmolive to $90 | CL Stock News
Colgate-Palmolive (CL) Target Price Lowered by Citigroup's Latest Analyst Rating | CL Stock News
Colgate-Palmolive (CL) Target Price Lowered by Citigroup's Latest Analyst Rating | CL Stock News
Colgate-Palmolive Analysts Cut Their Forecasts After Q3 Earnings
Colgate-Palmolive Company (NYSE: CL) reported downbeat third-quarter earnings on Friday . The consumer products giant reported third-quarter adjusted earnings per share of 91 cents, beating the analy...
Colgate-Palmolive Analysts Cut Their Forecasts After Q3 Earnings
Colgate-Palmolive Company (NYSE:CL) reported downbeat third-quarter earnings on Friday.
Colgate-Palmolive (CL) Price Target Lowered by Morgan Stanley | CL Stock News
Colgate-Palmolive (CL) Price Target Lowered by Morgan Stanley | CL Stock News
JP Morgan Lowers Price Target for Colgate-Palmolive (CL) to $87 | CL Stock News
JP Morgan Lowers Price Target for Colgate-Palmolive (CL) to $87 | CL Stock News
Colgate-Palmolive (CL) Receives Lower Price Target from Evercore ISI | CL Stock News
Colgate-Palmolive (CL) Receives Lower Price Target from Evercore ISI | CL Stock News
Wells Fargo Maintains Underweight Rating on Colgate-Palmolive (CL) | CL Stock News
Wells Fargo Maintains Underweight Rating on Colgate-Palmolive (CL) | CL Stock News